Skip to content
Screener

Discontinued — last reported Q1 '26

Income Tax at other companies

Amgen logo
AmgenAMGN
$393M+189%
Moderna logo
ModernaMRNA
$15M+114%
Immunovant, Inc. logo
Immunovant, Inc.IMVT
$1.55M+921%
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$770M+67.4%
AbbVie logo
AbbVieABBV
$662M+8.0%
CNT
Canton Strategic HoldingsCNTN
-$4.22M-173%

Segments

By geography

See full
Switzerland$79.89M
United States$53.47M+11.0%
Bermuda$0

By segment

See full
Reportable Segment-$3.96M-185%

Other financials

Income statement

See full
Revenue$1.4M-33.5%
Operating income-$366.0M-28.5%
Net income-$189.8M+15.0%
EPS (diluted)-$0.26+21.2%

Balance sheet

See full
Cash & equivalents$77.1M-18.7%
Total debt$107.2M+7.5%
Total equity$4.2B-2.6%
Total assets$5.3B+5.4%

Cash flow

See full
Operating cash flow-$270.5M-32.4%
CapEx$419.0K-89.6%
Free cash flow-$270.9M-30.0%

Valuation

See full
Market cap$25.37B+219%
Enterprise value$25.4B+219%
P/S3,368×+3,026×

Profitability

See full
Operating margin-9,130.5%-13,995pp
Net margin-6,079.9%-6,193pp
FCF margin-10,901%-22,382pp

Returns & leverage

See full
Return on equity-17.1%-17.7pp
Debt / equity0.0×
Current ratio16.7×-23.8×

Where this comes from

Reported directly by Roivant Sciences in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The source filing: Roivant Sciences’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 7:28 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q2 2026
Accession
0001635088-26-000090
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025
Interest income(36,922)(48,322)
Other expense, net2,13011,208
Loss before income taxes(294,564)(269,262)
Income tax (benefit) expense(3,958)4,649
Net loss(290,606)(273,911)
Net loss attributable to noncontrolling interests(100,769)(50,556)
Net loss attributable to Roivant Sciences Ltd.$(189,837)$(223,355)
Net loss per common share—basic and diluted$(0.26)$(0.33)

Item 1. Financial Statements (Unaudited).

FAQ

What is Roivant Sciences's income tax?
Roivant Sciences (ROIV) reported income tax of -$3.96M in Q2 2026.
How has Roivant Sciences's income tax changed year-over-year?
Roivant Sciences's income tax decreased by 185.1% year-over-year, from $4.65M to -$3.96M.
What does income tax mean?
Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.

Ask your AI about Roivant Sciences's income tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude